FMB Oxford supplies BioMAX beamline

FMB Oxford was very pleased to have been chosen to provide the equipment for the BioMAX beamline, the first operational macromolecular crystallography beamline at MAX IV. This included a highly stable Horizontal Double Crystal Monochromator/Cryocooler combination, Horizontal and Vertical Focussing Mirrors and Diagnostic Modules (including White Beam Stop, Bremsstrahlung Stop and Fluorescent Screens). This beamline was successfully manufactured, shipped and installed at MAX IV during 2015/6.

This short video shows Thomas Ursby, Beamline Manager, explaining about the first users and experiments. As its name suggests, the BioMAX beamline will focus on the study of biology at a molecular level helping to develop new drugs and fight diseases to improve human health.

The beamline took 5 years from concept to first users and is still a few months from full operation, but an important goal has been reached. FMB Oxford would like to congratulate all of the Staff at MAX IV associated with the beamline and also the first users from the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden on achieving such a significant milestone.

The picture shown at the top of the post shows the crystal structure of beta-Ketoacyl-acyl carrier protein reductase (FabG) with the cofactor NAPD bound in each active site. This is a key component in the type II fatty acid synthase system. The BioMAX beamline at Max IV and the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden are acknowledged in the reproduction of this image.